The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 02, 2014

Filed:

Aug. 26, 2013
Applicant:

Affinium Pharmaceuticals, Inc., Toronto, CA;

Inventors:

John J. Partridge, Chapel Hill, NC (US);

John Colucci, Kirkland, CA;

Yves Gareau, Notre-Dame de l'ile-Perrot, CA;

Michel Therien, Laval, CA;

Robert Zamboni, Beaconsfield, CA;

Barry Hafkin, Austin, TX (US);

Anthony Marfat, Mystic, CT (US);

Helmi Zaghdane, Pincourt, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 57/00 (2006.01); A61K 31/675 (2006.01); C07F 9/06 (2006.01); C07F 9/28 (2006.01); C07F 9/6561 (2006.01); C07F 9/58 (2006.01); C07F 9/60 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07F 9/582 (2013.01); C07F 9/6561 (2013.01); A61K 31/675 (2013.01); C07F 9/60 (2013.01); A61K 45/06 (2013.01);
Abstract

In part, the present disclosure is directed to prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide compounds with significant solubility and bioavailability profiles.


Find Patent Forward Citations

Quick Actions:

Partridge, John. (2014). Prodrug derivatives of (e)-n-methyl-n-((3-m ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (U.S. Patent No. 8901105). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8901105

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…